Human proteins with target sites of multiple post-translational modification types are more prone to be involved in

Qianli Huang1, Jinhui Chang, Man Kit Cheung

  • 1School of Life Sciences, The Chinese University of Hong Kong , Shatin, Hong Kong SAR 852000, China.

Insights

Many proteins with multiple post-translational modifications (PTMs) are linked to diseases. These Mtp-proteins play crucial roles in cellular processes and disease development, often acting as network hubs.

Area of Science:

  • Molecular Biology
  • Systems Biology
  • Biochemistry

Background:

  • Proteins undergo post-translational modifications (PTMs) that regulate their function.
  • Proteins with multiple PTM types (Mtp-proteins) are increasingly associated with diseases like cancer.
  • Mechanisms linking Mtp-proteins to disease pathogenesis are not well understood.

Purpose of the Study:

  • To investigate the association between human Mtp-proteins and disease.
  • To systematically characterize the features of Mtp-proteins.
  • To explore the role of Mtp-proteins in disease development.

Main Methods:

  • Analysis of human Mtp-protein datasets.
  • Characterization of protein features, including PTM sites, protein-protein interactions (PPIs), and subcellular localization.
  • Examination of intrinsically disordered regions and PTM effects on PPI stability.

Main Results:

  • Mtp-proteins are significantly more involved in disease than proteins without PTMs.
  • Mtp-proteins are enriched in protein complexes, act as network hubs, and have specific functional roles (e.g., chromatin dynamics).
  • Combinations of PTMs dramatically alter protein-protein interaction stability, more so than single PTM events.

Conclusions:

  • Mtp-proteins are key players in disease development.
  • Understanding Mtp-protein characteristics offers insights into disease mechanisms.
  • PTM combinations significantly impact protein interactions and cellular functions relevant to disease.

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.2K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.1K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
7.8K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Protein Glycosylation01:25

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
8.4K